RAS–MAPK Reactivation Facilitates Acquired Resistance in FGFR1-Amplified Lung Cancer and Underlies a Rationale for Upfront FGFR–MEK Blockade

B Bockorny, M Rusan, W Chen, RG Liao, Y Li… - Molecular cancer …, 2018 - AACR
The FGFR kinases are promising therapeutic targets in multiple cancer types, including lung
and head and neck squamous cell carcinoma, cholangiocarcinoma, and bladder cancer …
被引用次数：54 相关文章
[HTML] nih.gov

[HTML][HTML] RAS-MAPK reactivation facilitates acquired resistance in FGFR1-amplified lung cancer and underlies a rationale for upfront FGFR-MEK blockade

B Bockorny, M Rusan, W Chen, RG Liao… - Molecular cancer …, 2018 - ncbi.nlm.nih.gov
Abstract The Fibroblast Growth Factor Receptor (FGFR) kinases are promising therapeutic
targets in multiple cancer types including lung and head and neck squamous cell …

RAS-MAPK Reactivation Facilitates Acquired Resistance in FGFR1-Amplified Lung Cancer and Underlies a Rationale for Upfront FGFR-MEK Blockade.

B Bockorny, M Rusan, W Chen, RG Liao… - Molecular Cancer …, 2018 - europepmc.org
Abstract The Fibroblast Growth Factor Receptor (FGFR) kinases are promising therapeutic
targets in multiple cancer types including lung and head and neck squamous cell …

RAS-MAPK Reactivation Facilitates Acquired Resistance in FGFR1-Amplified Lung Cancer and Underlies a Rationale for Upfront FGFR-MEK Blockade

B Bockorny, M Rusan, W Chen, RG Liao, Y Li… - Molecular Cancer …, 2018 - pure.au.dk
The FGFR kinases are promising therapeutic targets in multiple cancer types, including lung
and head and neck squamous cell carcinoma, cholangiocarcinoma, and bladder cancer …

RAS–MAPK Reactivation Facilitates Acquired Resistance in FGFR1-Amplified Lung Cancer and Underlies a Rationale for Upfront FGFR–MEK Blockade

B Bockorny, M Rusan, W Chen, RG Liao, Y Li… - Molecular Cancer …, 2018 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> The FGFR kinases are promising therapeutic
targets in multiple cancer types, including lung and head and neck squamous cell …

RAS-MAPK Reactivation Facilitates Acquired Resistance in FGFR1-Amplified Lung Cancer and Underlies a Rationale for Upfront FGFR-MEK Blockade

B Bockorny, M Rusan, W Chen… - Molecular cancer …, 2018 - pubmed.ncbi.nlm.nih.gov
The FGFR kinases are promising therapeutic targets in multiple cancer types, including lung
and head and neck squamous cell carcinoma, cholangiocarcinoma, and bladder cancer …

RAS-MAPK Reactivation Facilitates Acquired Resistance in FGFR1-Amplified Lung Cancer and Underlies a Rationale for Upfront FGFR-MEK Blockade.

B Bockorny, M Rusan, W Chen, RG Liao… - Molecular Cancer …, 2018 - europepmc.org
Abstract The Fibroblast Growth Factor Receptor (FGFR) kinases are promising therapeutic
targets in multiple cancer types including lung and head and neck squamous cell …